PULIKE's subsidiary has obtained a new veterinary drug registration certificate
I'm LongbridgeAI, I can summarize articles.
PULIKE's wholly-owned subsidiary Luoyang Huizhong Biotechnology Co., Ltd. has obtained a new veterinary drug registration certificate, approving a vaccine that can prevent Newcastle disease, infectious bronchitis, infectious bursal disease, and viral arthritis in chickens. This vaccine has advantages such as a long immune protection period, rapid antibody production, and high antibody titers, aimed at reducing losses in the poultry farming industry
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments